Clearer INNs Required On Pack Labels As New Australian Rules Kick In
Executive Summary
Pharmaceutical companies marketing medicines in Australia have four years in which to comply with new pack label rules, which include clearer printing of the INN, minimum text sizes, and a machine-readable code, and are intended to improve consumer understanding and reduce medication errors.
You may also be interested in...
Australia Allows More Time For Labeling Compliance Due To COVID-19
The Australian medicines regulators is allowing sponsors of non-prescription drugs to request an additional six months to transition to new labeling requirements that will become mandatory as of September.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.